[Unified assessment of adverse events of multiple sclerosis disease modifying drugs.] Kasatkin DS, Spirin NN, Boĭko AN, Vlasov IV Zh Nevrol Psikhiatr Im S S Korsakova. 2014; 114(2 Vypusk 2 Rasseiannyi skleroz):78-82. PMID: 24662361. Abstract CommentRecommendBookmarkWatch